Tumor necrosis factor-α and malnutrition-induced inhibition of diaphragm fiber growth in young rats

Journal of Applied Physiology

Volumn 99, Issue 5, 2005, Pages 1649-1657

  Lewis, Michael I ^a,b,c   Da, Xiaoyu ^a   Li, Hongmei ^a   Fournier, Mario ^a,b  

^a BURNS AND ALLEN RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Cytokines; Muscle wasting; Nutritional depletion; p38; Respiratory muscles

Indexed keywords

MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; SOMATOMEDIN C; SYNAPTOPHYSIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; BODY WEIGHT; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DIAPHRAGM MUSCLE; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; GROWTH INHIBITION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INHIBITION KINETICS; MALE; MALNUTRITION; MUSCLE ATROPHY; MUSCLE GROWTH; NONHUMAN; NUCLEOTIDE SEQUENCE; NUTRITION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SECOND MESSENGER;

ANIMALS; ANTIBODIES, MONOCLONAL; BODY WEIGHT; DIAPHRAGM; INSULIN-LIKE GROWTH FACTOR I; MALE; MALNUTRITION; MUSCLE FIBERS; MYOSIN HEAVY CHAINS; ORGAN SIZE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 27544508870     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/japplphysiol.00238.2005     Document Type: Article

References (54)

1. Alzuherri H and Chang KC. Calcineurin activates NF-κB in skeletal muscle C2C12 cells. Cell Signal 15: 471-478, 2003.
2. Anker SD and Rauchaus M. Insights into the pathogenesis of chronic heart failure: immune activation and cachexia. Curr Opin Cardiol 14: 211-216, 1999.
3. Borst SE, Lee Y, Conover CF, Shek EW, and Bagby GJ. Neutralization of tumor necrosis factor alpha reverses insulin resistance in skeletal muscle, but not adipose tissue. Am J Physiol Endocrinol Metab 287: E934-E938, 2004.
4. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
5. Carbo N, Busquets S, van Royen M, Alvarez B, Lopez-Soriano FJ, and Argiles JM. TNF-α is involved in activating DNA fragmentation in skeletal muscle. Br J Cancer 86: 1012-1016, 2002.
6. Cheema IR, Hermann C, Postell S, and Barnes P. Effect of chronic excess of tumour necrosis factor-alpha on contractile proteins in rat skeletal muscle. Cytobios 103: 169-176, 2000.
7. De Freitas I, Fernandez-Somoza M, Essenfeld-Sekler E, and Cardier JE. Serum levels of the apoptosis-associated molecules, tumor necrosis factor-α/tumor necrosis factor type-I receptor and Fas/FasL, in sepsis. Chest 125: 1980-1982, 2004.
8. De Godoy I, Donahoe M, Calhoun WJ, Mancino J, and Rogers MM. Elevated TNF-α production by peripheral blood monocytes of weight-losing COPD patients. Am J Respir Crit Care Med 153: 633-638, 1996.
9. Di Francia M, Barbier D, Mege JL, and Orehek J. Tumor necrosis factor-α levels and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 150: 1453-1455, 1994.
10. Duan RS, Wang HB, Yang JS, Scallon B, Link H, and Xiao BG. Anti-TNF-alpha antibodies suppress the development of experimental autoimmune myasthenia gravis. J Autoimmun 19: 169-174, 2002.
11. Fernandez-Celemin L, Pasko N, Blomart V, and Thissen JP. Inhibition of muscle insulin-like growth factor I expression by tumor necrosis factor-α. Am J Physiol Endocrinol Metab 283: E1279-E1290, 2002.
12. Fournier M and Lewis MI. Functional, cellular and biochemical adaptations to elastase-induced emphysema in the hamster medial scalene. J Appl Physiol 88: 1327-1337, 2000.
13. Fournier M, Wang C, Kamangar N, Li H, Chen YDI, and Lewis MI. Skeletal muscle gene expression profile in response to short-term malnutrition (Abstract). Am J Respir Crit Care Med 167: A963, 2003.
14. Giovambattista A, Spinedi E, Sanjurjo A, Chisari A, Rodrigo M, and Perez N. Circulating and mitogen-induced tumor necrosis factor (TNF) in malnourished children. Medicina (B Aires) 60: 339-342, 2000.
15. Goodman MN, McElaney MA, and Ruderman NB. Adaptation to prolonged starvation in the rat: curtailment of skeletal muscle proteolysis. Am J Physiol Endocrinol Metab 241: E321-E327, 1981.
16. Guttridge DC, Mayo MW, Madrid LV, Wang CY, and Baldwin AS Jr. NF-κB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science 289: 2363-2366, 2000.
17. Jacobson L, Zurakowski D, and Majzoub JA. Protein malnutrition increases plasma adrenocorticotropin and anterior pituitary ptoopiomelanocortin messenger ribonucleic acid in the rat. Endocrinology 138: 1048-1057, 1997.
18. Kielman AA and McCord C. Weight-for-age as an index of risk of death in children. Lancet 1: 1247-1250, 1978.
19. Kwon J, Chung IY, and Benveniste EN. Cloning and sequence analysis of the rat tumor necrosis factor-encoding genes. Gene 132: 227-236, 1993.
20. Lang CH, Frost RA, Nairn AC, MacLean DA, and Vary TC. TNF-α impairs heart and skeletal muscle protein synthesis by altering translation initiation. Am J Physiol Endocrinol Metab 282: E336-E347, 2002.
21. Lang CH, Silvis C, Deshpande N, Nystrom G, and Frost RA. Endotoxin stimulates in vivo expression of inflammatory cytokines tumor necrosis factor alpha, interleukin-1β, -6, and high-mobility-group protein-1 in skeletal muscle. Shock 19: 538-546, 2003.
22. Lewis MI, Feinberg AT, and Fournier M. IGF-I and/or growth hormone preserve diaphragm fiber size with moderate malnutrition. J Appl Physiol 85: 189-197, 1998.
23. Lewis MI, Fournier M, Yeh AY, Micevych PE, and Sieck GC. Alterations in diaphragm contractility after nandrolone administration: an analysis of potential mechanisms. J Appl Physiol 86: 985-992, 1999.
24. Lewis MI, Kamangar N, Xu NX, Da X, and Fournier M. Influence of short-term malnutrition on muscle IGF-I signaling pathways (Abstract). Am J Respir Crit Care Med 167: A963, 2003.
25. Lewis MI, Li H, Huang ZS, Biring MS, Cercek B, and Fournier M. Influence of varying degrees of malnutrition on IGF-I expression in the rat diaphragm. J Appl Physiol 95: 555-562, 2003.
26. Lewis MI and Sieck GC. Effect of acute nutritional deprivation on diaphragm structure and function in adolescent rats. J Appl Physiol 73: 974-978, 1992.
27. Lewis MI and Sieck GC. Effect of acute nutritional deprivation on diaphragm structure and function. J Appl Physiol 68: 1938-1944, 1990.
28. Li YP, Chen Y, John J, Moylan J, Jin B, Mann DL, and Reid MB. TNF-α acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin 1/MAFbx in skeletal muscle. FASEB J 19: 362-370, 2005.
29. Li YP, Lecker SH, Chen Y, Waddell ID, Goldberg AL, and Reid MB. TNF-α increases ubiquitin-conjugating activity in skeletal muscle by up-regulating UbcH2/E220k. FASEB J 17: 1048-1057, 2003.
30. Li YP and Reid MB. NF-κB mediates the protein loss induced by TNF-α in differentiated skeletal muscle myotubes. Am J Physiol Regul Integr Comp Physiol 279: R1165-R1170, 2000.
31. Li YP, Schwartz RJ, Waddell ID, Holloway BR, and Reid MB. Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated NF-κB activation in response to tumor necrosis factor α. FASEB J 12: 871-880, 1998.
32. Libera LD, Ravara B, Volterrani M, Gobbo V, Barbera MD, Angelini A, Betto DD, Germinario E, and Vescovo G. Beneficial effects of GH/IGF-I on skeletal muscle atrophy and function in experimental heart failure. Am J Physiol Cell Physiol 286: C138-C144, 2004.
33. Llovera M, Carbo N, Garcia-Martinez C, Costelli P, Tessitore L, Baccino FM, Agell N, Bagby GJ, Lopez-Soriano FJ, and Argiles JM. Anti-TNF treatment reverts increased muscle ubiquitin gene expression in tumour-bearing rats. Biochem Biophys Res Commun 221: 653-655, 1996.
34. Llovera M, Garcia-Martinez C, Agell N, Lopez-Soriano FJ, and Argiles JM. TNF can directly induce the expression of ubiquitin-dependent proteolytic system in rat soleus muscles. Biochem Biophys Res Commun 230: 238-241, 1997.
35. Mitch WE and Goldberg AL. Mechanisms of muscle wasting. N Engl J Med 335: 1897-1905, 1996.
36. Moldawer LL and Sattler FR. Human immunodeficiency virus-associated wasting and mechanisms associated with inflammation. Semin Oncol 25: 73-81, 1998.
37. Oster MH, Fielder PJ, Levin N, and Cronin MJ. Adaptation of the growth hormone and insulin-like growth factor-I axis to chronic and severe calorie or protein malnutrition. J Clin Invest 95: 2258-2265, 1995.
38. Oster MH, Levin N, Fielder PJ, Robinson ICAF, Baxter RC, and Cronin MJ. Developmental differences in the IGF-I system response to severe and chronic malnutrition. Am J Physiol Endocrinol Metab 270: E646-E653, 1996.
39. Philip R and Epstein LB. Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, gamma-interferon, and interleukin-1. Nature 323: 86-89, 1986.
40. Piechaczyk M, Blanchard JM, Marty L, Dani C, Panabieres F, ElSabouty S, Fort P, and Jeanteur P. Post-transcriptional regulation of glyceraldehyde-3- phosphate dehydrogenase gene expression in rat tissues. Nucleic Acids Res 12: 6951-6963, 1984.
41. Pollack MM, Wiley JS, and Holbrook PR. Early nutritional depletion in critically ill children. Crit Care Med 9: 580-583, 1981.
42. Roberts CT Jr, Lasky SR, Lowe WL Jr, Seaman WT, and LeRoith D. Molecular cloning of rat insulin-like growth factor I complementary deoxyribonucleic acids: differential messenger ribonucleic acid processing and regulation by growth hormone in extrahepatic tissues. Mol Endocrinol 1: 243-248, 1987.
43. Sacheck JM, Ohtsuka A, McLary SC, and Goldberg AL. IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1. Am J Physiol Endocrinol Metab 287: E591-E601, 2004.
44. Saghizadeh M, Ong JM, Garvey WT, Henry RR, and Kern PA. The expression of TNF-α by human muscle: relationship to insulin resistance. J Clin Invest 97: 1111-1116, 1996.
45. Sandri M, Sandri C, Gilbert A, Skurk C, Calabria E, Picard A, Walsh K, Schiaffino S, Lecker SH, and Goldberg AL. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117: 399-412, 2004.
46. Schiaffino S, Gorza L, Sartore S, Saggin L, Ausoni S, Vianello M, Gundersen K, and Lomo T. Three myosin heavy chain isoforms in type 2 skeletal muscle fibers. J Muscle Res Cell Motil 10: 197-205, 1989.
47. Shealy DJ, Wooley PH, Emmell E, Volk A, Rosenberg A, Treacy G, Wagner CL, Mayton L, Griswold DE, and Song XYR. Anti-TNF-α antibody allows healing of joint damage in polyarthritic transgenic mice. Arthritis Res 4: R7, Epub Jun 28, 2002.
48. Spangenburg EE, Williams JH, Roy RR, and Talmadge RJ. Skeletal muscle calcineurin: influence of phenotype adaptation and atrophy. Am J Physiol Regul Integr Comp Physiol 280: R1256-R1260, 2001.
49. Stitt TN, Drujan D, Clarke BA, Panaro F, Timofeyva Y, Kline WO, Gonzalez M, Yancopoulos GD, and Glass DJ. The IGF-I/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol Cell 14: 395-403, 2004.
50. Tartaglia LA and Goedeel DV. Two TNF receptors. Immunol Today 13: 151-153, 1992.
51. Thissen JP, Ketelslegers JM, and Underwood LE. Nutritional regulation of the insulin-like growth factors. Endocr Rev 15: 80-101, 1994.
52. Tisdale MJ. Wasting in cancer. J Nutr 129: 243-246, 1999.
53. VandeHaar M, Moats-Swtaats BM, Davenport ML, Walker JL, Ketelslegers JM, Sharma BK, and Underwood LE. Reduced serum concentrations of insulin-like growth factor-I (IGF-I) in protein-restricted growing rats are accompanied by reduced IGF-I mRNA levels in liver and skeletal muscle. J Endocrinol 130: 305-312, 1991.
54. Visser M, Pahor M, Taaffe DR, Goodpaster BH, Simonsick EM, Newman AB, Nevitt M, and Harris TB. Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study. J Gerontol A Biol Sci Med Sci 57: 326-332, 2002.